Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 264-120-7 | CAS number: 63393-96-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
oral: OECD 401, rat LD50 > 200 < 2000 mg/kg bw
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 200 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Acute oral toxicity
In accordance with column 2 of REACH Annex VIII, testing of the acute toxicity is not appropriate as the target substance is classified as corrosive to the skin. However, two acute oral toxicity studies have already been conducted in 1987 and 1990. The key study, which is equivalent or similar to OECD Guideline 401, is summarized below (Henkel KGaA, TBD 981004, 1990).
The test substance was administered at concentrations of 200 and 2000 mg/kg bw by gavage to groups each 5 male and female Wistar rats. The observation period of 14 days included daily observations for clinical signs and mortality, and weighing the day before and on the day of application, as well as on days 2, 7 and 14. Necropsy of all animals was performed.
None of the animals exposed to 200 mg/kg bw died up to the end of the 14 day observation period. Only one male animal had to be sacrificed 52 hours post dosing, but this was due to a gavage error. No clinical signs could be observed and all animals showed a normal body weight gain.
4 male animals and all 5 female animals died within 30 hours after application of 2000 mg/kg bw. The fifth male animal died 48 hours after application. Onset of clinical signs was already 15 minutes after dosing for male animals and 2.5 hours for females. Severity of symptoms increased up to death of the animals. Clinical signs included: vocalization, piloerection, diarrhea, decreased activity, squatting posture which changed to belly-side location and belly location at later time points, brownish colored nose and/or snout and lid closure.
Gross pathology revealed no abnormal findings for the animals dosed with 200 mg/kg bw. Animals dosed with 2000 mg/kg bw showed the following pathological findings:
2 male and 5 female animals dosed with 2000 mg/kg bw showed a severe gaseous distention of the small intestine and the females additionally of the stomach. 1 female animal had a red discolored glandular stomach and the duodenum filled with liquid. 2 male animals and all 5 female animals showed a severe hydrothorax, 2 male animals had redness of the fundus area and moderate ascites. Additionally, 1 male animal had a filled small intestine, slight ascites and a slight hypothorax. The effects described, which occurred at the site of contact, could be interpreted as consequence of the corrosive potential of the test substance.
In conclusion, the LD50 was set to be > 200 < 2000 mg/kg bw and therefore Quarternary ammonium compounds, tri-C8 -10 -alkylmethyl, chlorides, needs to be classified as toxic (Cat.3, H301) according to CLP Regulation (EC) No. 1272/2008 (worst case) and (Xn, R22) according to DSD (67/548/EEC).
Acute inhalation toxicity:
In accordance with column 2 of REACH Annex VIII, testing of the acute toxicity is not appropriate as the substance is classified as corrosive to the skin.
Acute dermal toxicity:
In accordance with column 2 of REACH Annex VIII, testing of the acute toxicity is not appropriate as the substance is classified as corrosive to the skin.
Justification for classification or non-classification
Based on the results for acute oral and acute dermal toxicity, the substance needs to be classified according to the:
- Dangerous Substance Directive 67/548/EC - Xn, R22
- CLP Regulation (EC) No 1272/2008 - Cat.3, H301
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.